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Abstract
It is known that genetic variants can affect gene expression, but it is not yet completely clear through what mechanisms
genetic variation mediate this expression. We therefore compared the cis-effect of single nucleotide polymorphisms (SNPs)
on gene expression between blood samples from 1,240 human subjects and four primary non-blood tissues (liver,
subcutaneous, and visceral adipose tissue and skeletal muscle) from 85 subjects. We characterized four different
mechanisms for 2,072 probes that show tissue-dependent genetic regulation between blood and non-blood tissues: on
average 33.2% only showed cis-regulation in non-blood tissues; 14.5% of the eQTL probes were regulated by different,
independent SNPs depending on the tissue of investigation. 47.9% showed a different effect size although they were
regulated by the same SNPs. Surprisingly, we observed that 4.4% were regulated by the same SNP but with opposite allelic
direction. We show here that SNPs that are located in transcriptional regulatory elements are enriched for tissue-dependent
regulation, including SNPs at 39 and 59 untranslated regions (P=1.84610
25 and 4.7610
24, respectively) and SNPs that are
synonymous-coding (P=9.9610
24). SNPs that are associated with complex traits more often exert a tissue-dependent effect
on gene expression (P=2.6610
210). Our study yields new insights into the genetic basis of tissue-dependent expression
and suggests that complex trait associated genetic variants have even more complex regulatory effects than previously
anticipated.
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Introduction
It has become clear that human genetic variants, such as single
nucleotide polymorphisms (SNPs), can in cis affect the expression
of nearby genes [1], [2]. Many loci exist that contain genetic
variants that affect gene expression (expression quantitative loci,
eQTL, usually assessed by investigating single nucleotide poly-
morphisms (SNPs) and expression probes that are within 250 kb
up to 1 Mb apart). These cis-eQTL analyses have been performed
in many different human tissues and cell types, including
lymphoblastoid cell lines (LCL) [3], [4], liver [5]–[7], blood [8],
[9], brain [10], [11], adipose tissues [6], [8], skin [12], [13] and
primary fibroblasts [12]. However, considerable heterogeneity of
cis-eQTL effects is possible between different tissues: A recent
study reported that the proportion of heritability due to gene
expression attributable to cis-regulation differs between tissues
(37% in blood and 24% in adipose tissue) [14]. By comparing the
overlap of significant cis-eQTL at a predefined threshold, estimates
on the tissue-dependence of cis-eQTL were between 30% (liver,
adipose tissues) and 70–80% (LCLs, fibroblasts, T cells) [8], [9],
PLoS Genetics | www.plosgenetics.org 1 January 2012 | Volume 8 | Issue 1 | e1002431[15], [16]. However, due to statistical power issues, it is likely that
the tissue-dependency of cis-eQTL has been overestimated by
studies solely assessing the overlap of cis-eQTL between tissues
based on a certain threshold. Realizing this problem, Ding et al.
used a refined statistical method to estimate the percentage of
overlap by adding a power parameter to the model [12]. They
reported that only 30% of cis-eQTL in LCLs were not shared with
fibroblast cis-eQTL. Similarly, a recent study by Nica et al. [13]
examined the tissue-dependence of cis-eQTL in three human
tissues (LCL, skin and fat) in a continuous manner by quantifying
the proportion of overlap of cis-eQTL from the enrichment of low
P-values. They observed that 29% of cis-eQTL appear to be
exclusively tissue-dependent, and also observed that the effect sizes
of 10–20% of the cis-eQTL present in multiple tissues differ per
tissue type. These observations are in line with a large-scale
transcriptomic analysis of 46 human tissues, which found that
while only 6.0% of genes were ubiquitously expressed across all the
assessed tissues, 3.1% genes were only expressed in a single tissue
[17].
To gain a better understanding of this subtle regulation of
tissue-dependent regulation and to address the question of how
genetic variants mediate tissue-dependent expression, we com-
pared cis-regulation between whole peripheral blood from a large
cohort of 1,240 individuals and four smaller primary human
tissues (liver, subcutaneous adipose tissue (SAT), visceral adipose
tissue (VAT) and skeletal muscle) obtained from a set of 85
subjects. We first applied a robust sampling procedure to estimate
accurately how often genes showed different cis-eQTL effects
between tissues. We then investigated in what way genes are
differently associated with SNPs in different tissues. Finally, we
assessed various functional properties for the SNPs involved in
tissue-dependent cis-regulation and their association with complex
traits.
Results
Cis-eQTL Mapping in Five Primary Tissues
For this study, we collected data for four different tissues from a
set of 85 unrelated obese Dutch subjects. We successfully collected
data on 74 liver samples, 62 muscle samples, 83 subcutaneous
adipose tissue (SAT) samples and 77 visceral adipose tissue (VAT)
samples (for 48 individuals all four tissues were available). The fifth
tissue, blood, was collected from a different group of 1,240
unrelated Dutch individuals (Table S1). The gene expression levels
in all five tissues were profiled using the same Illumina
HumanHT12 v3 platform (see Materials and Methods). After
normalization, we further removed strong expression differences
between these tissues by removing the 50 principal components
from this dataset and using the residuals for further analysis
(described in [18] and Materials and Methods, Figure S1). We first
performed cis-eQTL analysis in each of these datasets separately,
by testing the correlation between SNPs and probes that were
mapping within 1 Mb distance. At a false-discovery rate (FDR) of
0.05 level, we identified a non-overlapping set of 195,078 probe-
SNP pairs that were significant in at least one of the tissues under
study: 4,700 probe-SNP pairs were significantly associated in liver,
7,161 pairs significantly in SAT, 5,323 pairs significantly in VAT,
1,971 pairs significantly in muscle, and 190,278 pairs significant in
blood (Figure S2). Owing to the much larger sample size, 182,569
probe-SNP pairs (93.6%) were solely detected in blood, while only
601 probe-SNP pairs (0.31%) were significant in each of the five
different tissues (Figure S3). Although a previous study showed that
the heritability of gene expression levels are higher in blood (37%)
compared to adipose tissue (24%) [14], we believe that the large
difference in the detected probe-SNP pairs between blood and
non-blood tissues is due to statistical power issues that result from
substantial sample size differences. As we had initially run cis-
eQTL analyses in each of the tissues separately, we subsequently
conducted a weighted Z-score meta-analysis across the four non-
blood tissues and detected 23,878 probe-SNP pairs at FDR of
0.05. Out of these, 23.2% (5,550 out of 23,878 probe-SNP pairs)
had not been identified in any of the single-tissue analyses (Figure
S4). In total, the single-tissue analyses and meta-analysis yielded a
non-overlapping set of 200,629 significant probe-SNP pairs,
corresponding to 103,968 unique expression altering SNPs
(eSNPs) and 11,618 probes (eProbes) that represent 8,561 unique
genes (eGenes) (Figure S2).
Cis-eQTL Effects Differ per Tissue Type
To assess the tissue-dependency of the cis-eQTL, we compared
the Spearman correlation of each probe-SNP pair between tissues.
However, due to the small sample sizes of the non-blood datasets
we had very limited statistical power to determine whether there
were cis-eQTL effect differences between non-blood tissues. We
therefore confined ourselves to comparisons between the large
blood dataset and each of the smaller non-blood tissues. To correct
for sample size differences, we employed a resampling procedure,
permitting us to derive an empirical distribution of association Z-
scores (calculated based on the Spearman correlation) of each
probe-SNP pair in blood of the same sample size as in non-blood
tissues (see Materials and Methods; Figure S5). We observed that
18,456 pairs (9.2% of 200,629 probe-SNP pairs) showed a
significantly different Z-score between blood and at least one of
the non-blood tissues at P,6.23610
28 (corresponding to a
conservative Bonferroni-corrected P,0.05), implying a discordant
association between blood and non-blood tissues. The remaining
182,173 probe-SNP pairs, which we called ‘‘concordant associa-
tion’’, had similar association Z-scores between the tissues under
study (Figure S2). The ‘‘discordant associations’’ accounted for
15.4% of the eSNPs (15,974 out of 103,968 eSNPs), 28.7% of the
eProbes (3,330 out of 11,618 eProbes), and 34.1% of the unique
eGenes (2,919 out of 8,561 eGenes) (Table S2 and Figure S2). We
further assessed for each probe-SNP pair, whether the discordance
was detected between blood and multiple non-blood tissues, or
only between blood and one specific non-blood tissue. We
observed that 14,388 probe-SNP pairs (78.0% of the 18,456
discordant probe-SNP pairs) only showed a discordant effect
between blood and one specific non-blood tissue. Only 125 probe-
SNP pairs (corresponding to 31 eProbes) showed a discordant
Author Summary
Gene expression can be affected by genetic variation, e.g.
single nucleotide polymorphisms (SNPs). These are called
expression-affecting SNPs or eSNPs. Gene expression levels
are known to vary across different tissues in the same
individual, despite the fact that genetic variation is the
same in these tissues. We explored the different mecha-
nisms by which genetic variants can mediate tissue-
dependent gene expression. We observed that the genetic
variants that associated with complex traits are more likely
to affect gene expression in a tissue-dependent manner.
Our results suggest that complex traits are even more
complex than we had anticipated, and they underline the
great importance of using expression data from tissues
relevant to the disease being studied in order to further
the understanding of the biology underlying the disease
association.
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the four non-blood tissues but markedly different regulation in
blood (Figure S6). As such these results reveal there are
considerable differences in the genetically determined regulation
of gene expression between liver, SAT, VAT and muscle tissues,
even though the RNA from these tissues had been derived from
the same individuals at was collected at exactly the same time.
To ensure that our sampling procedure was robust, we used the
same procedure to assess how often our method incorrectly
concluded that a probe-SNP Spearman correlation differed
between two independent eQTL datasets in the same peripheral
blood tissue: We used the 1,240 blood samples as discovery set and
used an independent set of 229 blood samples as validation whose
expression was profiled using Illumina H8-v2 chips, [18], [19], see
Methods and Materials. In this analysis, our method incorrectly
deemed that 0.45% of the probe-SNP pairs showed a significant
difference at the previously used P,6.23610
28 level (Figure S7).
In our comparisons between blood and non-blood tissues we had
observed that 9.2% of the probe-SNP pairs showed a discordant
effect, which is substantially higher and indicates that the number
of discordant associations that we identified when comparing
different tissues are not expected by chance (Fisher’s exact test:
OR=20.6 and P,10
2300). We also assessed whether imputation
accuracy differences between datasets might confound some of the
results, but did not find evidence this to be the case (see Materials
and Methods).
Properties of eSNPs
For the significant 200,629 probe-SNP pairs, we observed that
for 146,480 pairs (73.0%) the eSNPs were located within 250 kb
distance of the eProbe while 54,149 probe-SNP pairs (27.0%)
mapped between 250 kb and 1 Mb apart. Consistent with a
previous study [15], we observed that eSNPs at a larger distance
from the probes tend to have smaller effects (Figure S8). However,
we realize that due to extensive LD many different SNPs are
usually significantly correlated with one single cis-eQTL probe. To
address this, we performed step-wise conditional analyses in each
tissue type to ascertain whether there were multiple SNPs that
independently affected the expression levels of the same probe. We
observed this for 26.8% of the eProbes in the large blood dataset
(Table S3), (where for 2,794 out 10,443 eProbes we had detected
multiple independent eSNPs): We observed that the secondary,
tertiary and quaternary eSNPs usually map further away from the
probe (Wilcoxon test P=2.25610
266, Figure S9), potentially
reflecting some regulatory elements such as enhancers that usually
reside further away from genes. In the non-blood tissues, we lacked
statistical power to detect many secondary and tertiary effects
(Table S3).
Interestingly, there was a very high overlap between the
discordant eProbes (detected in our comparison across tissues) and
the eProbes with multiple independent effects in blood (detected in
the aforementioned analysis that solely used blood samples). Out
of the 10,443 eProbes in blood, 2,528 eProbes had discordant
association and 7,915 eProbes had concordant association.W e
observed that 47.5% of the discordant eProbes had multiple
independent eSNPs present in blood (1,202 out of 2,528); whereas
only 20.1% of the concordant eProbes had multiple independent
eSNPs (1,592 out of 8,219, Fisher’s exact test P=3.85610
281).
This observation suggests that for eProbes: 1) different independent
eSNPs can exist and 2) these independent eSNPs can exert an
effect in one tissue while they do not exert an effect in another
tissue.
We subsequently analyzed the most significant eSNP per eProbe
per tissue and the top eSNP per eProbe from the meta-analysis of
four non-blood tissues. In total, we ended up with 13,603 probe-
SNP pairs (12,549 top eSNPs, that were affecting 11,575 probes
pairs) these six analyses. Among them, 2,612 probe-SNP pairs
(19.2%) showed a discordant effect among tissues at
P=6.23610
28 level (genome-wide test level), accounting for
2,466 (19.7%) unique eSNPs.
We found that the top eSNPs with discordant effect had a
significantly higher minor allele frequency (MAF) than the
concordant top eSNPs (Wilcoxon test P=8.27610
221). The
eSNPs at a smaller distance from the eProbe (#250 kb) were more
likely to show a discordant effect compared to the eSNPs at larger
distance (250 kb–1 Mb distance, OR=1.62, P=3.6610
222,
Figure S10). Although we acknowledge that the top eSNPs do
not necessarily reflect the true causal variants, we annotated the
functional properties of the top eSNPs to understand the potential
roles of the eSNPs (irrespective of whether these reflect concordant
or discordant eProbes). We observed that the most of the eSNPs
were located in intragenic regions (67.0%) and intronic regions
(14.9%), where their function often remains undetermined.
Interestingly, eSNPs with discordant effect were (compared to
concordant eSNPs) significantly enriched for synonymous-coding
SNPs (Fisher’s exact P value 9.9610
24), and more often mapped
in the 39 and 59 untranslated regions (UTRs, Fisher’s exact P
values 1.84610
25 and 4.7610
24, respectively) (Figure 1).
As shown before, we observed that SNPs, associated with
complex traits and diseases, are more likely to be eSNPs [2], [6],
[8], [18], [19]. We subsequently analysed 1,954 trait-associated
SNPs (at P,5610
28, retrieved from the GWAS catalog per 16
September 2011) [20] and observed that 907 trait-associated SNPs
(46.4%) were eSNPs. Of these, 261 trait-associated eSNPs (28.7%)
showed discordant effects on gene expression, which is significantly
higher than what we observed for all 103,968 trait- and non-trait-
associated eSNPs (15.4% discordant, Fisher’s exact test
P=1.10610
233) and also significantly higher than if we compare
this to only the 12,549 top eSNPs (19.7% discordant, Fisher’s
exact test P=2.6610
210).
Four Categories of Tissue-Dependent Cis-Regulation
As we have shown above, discordant eProbes are more likely to
be influenced by multiple independent eSNPs. However, solely
assessing the discordance of a single SNP-probe pair does not
provide an extensive landscape of the tissue-dependent genetic
determinants of gene expression. To gain further insight into this,
we created ‘association profiles’ for the discordant eProbes and
compared these across tissues. An association profile refers to the
association Z-scores of all tested SNPs within 1 Mb distance of the
eProbe under study (see Materials and Methods), and takes into
account multiple SNPs and linkage disequilibrium. We created
such association profiles for 2,007 discordant eProbes 52 (521
eProbes from liver, 708 eProbes from SAT, 526 eProbes from VAT,
and 252 eProbes from muscle, Figure S2).
Upon inspection of these association profiles for the discordant
eProbes, we identified four main different categories of tissue-
dependent genetic regulation of gene expression. If the association
profiles for one single eProbe did not correlate at all between two
tissues, we further checked whether the eProbe was significant in
both tissues: If the probe had a significant association in one tissue
but not in the other, we deemed this ‘‘specific cis-regulation’’. If
instead the eProbe was significant in both tissues, but was associated
to different (unlinked) eSNPs in the different tissues, we deemed it
‘‘alternative cis-regulation’’ between tissues. For those association
profiles where two tissues showed a correlation, we checked the
direction and the effect size of allelic effect on gene expression. If
the allelic direction was the same and the effect size was different,
Mechanisms Underlying Tissue-Dependent cis-eQTL
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size’’. If the allelic direction was instead opposite, the probes had
tissue-dependent regulation with an ‘‘opposite allelic direction’’
(see Materials and Methods). We discuss each of these four
categories in detail below and in Figure 2 and Figure 3.
Specific regulation. Specific cis-regulation refers to a gene
that is cis-regulated in only one specific tissue. We found this type of
regulation is a common phenomenon as it accounted for on average
33.2% of the discordant eProbes (Figure 2). One well-established
example is the SORT1 gene at the 1p13 cholesterol locus, to which
SNPs map that affect low-density lipoprotein cholesterol (LDL-C)
and the risk of myocardial infarction (MI) in humans [21], [22].
Recently, it was shown that the functional variant rs12740374 alters
the binding site for C/EBP transcription factors and consequently
alters the hepatic expression of the SORT1 gene [23]. Our data
replicated this specific cis-regulation in liver (Figure 3A). The
association Z-score for rs12740374 with SORT1 expression
variation in liver was 8.24 (N=74, P=1.41610
215) but in blood
we observed no effect (Z-score=0.07, N=1,240, P=0.8), nor did
we observe any associations in SAT, VAT or muscle, and the
association profiles for this gene show no correlation between
different tissues (all spearman correlation P values.0.39). Thus, in
our data, rs12740374 only exerts an effect on SORT1 gene
expression in liver, although we did observe that SORT1 was
expressed abundantly in all tissues.
Alternative regulation. Alternative regulation between
tissues refers to a gene that is cis-associated with a SNP in a
particulartissue andassociated witha different,independent SNP in
another tissue. Such an alternative cis-regulation is also a common
phenomenon, as we found it applied to on average 14.5% of the
Figure 1. Functional Properties of eSNPs with tissue-dependent effect and concordant effect. The bar plot shows the frequency of the
eSNP per function property. The eSNPs were annotated using the web-based tool of SNP Annotation and Proxy Search (SNAP; http://www.
broadinstitute.org/mpg/snap/), based on the HapMap CEU population panel (release 22) and genome build 36.3. The asterisks indicate the
significance of Fisher’s exact test by comparing the eSNPs with concordant effect and with discordant effect, as given in the legend.
doi:10.1371/journal.pgen.1002431.g001
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example is the trans-membrane gene TMEM176A, also known as
hepatocellular carcinoma-associated antigen 112. The expression of
TMEM176A was associated with intronic SNP rs714885 in liver
(N=74, P=5.7610
26) but with the 19.5 kb upstream SNP
rs6464104 in blood (N=1,240, P=5.07610
2132) (Figure 3B).
These two SNPs are unlinked variants (r
2=0.002 and D9=0.054
based on the HapMap phase II CEU panel). We observed the same
alternative association for different probes of TMEM176A in an
independent liver eQTL dataset (profiled using a custom ink-jet
microarrays [7] and in the aforementioned independent blood
eQTL dataset that was profiled using Illumina HumanRef-8 v2
BeadChips) (Table S4) [18], [19]. This clearly shows that 1)
multiple, unrelated variants can sometimes affect exactly the same
gene, and 2) these independent variants sometimes only exert an
effect on the gene expression in a particular tissue.
Different effect size. The different effect size refers to a
common phenomenon that a gene is associated with the same SNP
with alleles that have the same direction of effect but with a
different magnitude in different tissues (Figure 2). For eProbe that
showed this, we observed a significantly positive correlation
between the association profiles of the tissues. We observed it
applies to on average 47.9% of the probes that show tissue-
dependent regulation (Figure S2), in line with a previous report
[13]. One example is the O-6-methylguanin-DNA-
methyltransferase (MGMT) gene that plays an important role in
DNA repair and which suppresses tumor development [24]. We
observed a cis-eQTL for MGMT across each of the five tissues.
However, the effect size in blood was substantially smaller than
that in SAT tissues (Figure 3C).
Opposite allelic direction. Surprisingly, we observed that
some genes were associated with the same SNPs in different tissues
Figure 2. cis-regulation of gene expression between tissues. The associated probe-SNP pairs were classified to be concordant or discordant
between tissues. The small pie plot shows the proportion of probes that have only concordant association (red part) or at least one discordant
association (blue part). The probes with discordant association were under tissue-dependent regulation and we characterized four different
mechanisms: specific regulation, alternative regulation, different effect size and opposite effect sizes. Their proportions are shown in the large blue
pie plot. The concordant cis-regulation and the four different mechanisms are illustrated by the correlation between SNP genotypes (AA, AG and GG)
and gene expression levels in two tissues: brown dots represent the expression of a gene in tissue 1 and purple dots the expression of a gene in
tissue 2.
doi:10.1371/journal.pgen.1002431.g002
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PLoS Genetics | www.plosgenetics.org 5 January 2012 | Volume 8 | Issue 1 | e1002431Figure 3. Case examples for tissue-dependent cis-regulation. (A) The liver-specific regulation of the SORT1 gene. (B) The alternative
regulation of the TMEM176A gene in blood and liver. (C) The cis-regulation for the MGMT gene had different effect sizes in blood and SAT. (D) The cis-
regulation for the DDT gene show opposite allelic direction between blood and liver. For each gene, the left panel shows the cis-eQTL association
profile in the corresponding tissue (liver or SAT, in blue) vs the association profile in blood (red). The x-axis is the genome position based on genome
build 36.3 (in Mb). The y-axis at the left is the association strength in terms of Z-score. The Z-score in blood has been weighted by the square root of
the sample size, corresponding to the compared tissue. The dashed green line indicates the significance level of association at FDR 0.05. We use the
absolute Z-scores to show the association in (A–C), but use the Z-scores in (D) for a better illustration of allelic direction. We assigned the association
Z-scores in blood a negative value. If the allelic direction in SAT is the same as that in blood, the Z-score in SAT is negative too; otherwise, the Z-score
in SAT is positive. The black line shows the recombination rate at this locus based on the HapMap II CEU panel and the scale is indicated on the right-
hand y-axis. The green line with arrow at the bottom shows the genome position of the gene and the arrow indicates the transcription direction. The
right panel shows the correlation of the Z-scores between two tissues. The r-value indicates the correlation coefficient of the Pearson correlation.
doi:10.1371/journal.pgen.1002431.g003
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between tissues. For a probe under this regulation, we then also
observed a strong negative correlation between its association
profiles across different tissues. This ‘‘opposite allelic direction’’
mechanism accounted for on average 4.4% of the probes under
tissue-dependent regulation (Figure 2), which is much less common
than the three previous mechanisms. However, this is still much
more often than would be expected by chance, as determined by a
comparison between two blood datasets in which we found the
allelic directions were nearly always identical (Figure S7). One
striking opposite allelic direction was observed to D-dopachrome
tautomerase (DDT), which showed completely opposite effects
between blood and liver (Figure 3D). Consistently, we found this
opposite effect in the independent liver [7] and blood
dataset,(H8v2), even when different probes were assessed. The
minor allele rs5751777-C was associated with higher expression in
liver (P=9.95610
222 in the discovery set and P=2.86610
2211 in
the validation set), but with lower expression in blood
(P=3.98610
2119 in the discovery set and P=4.37610
224 in the
validation set) (Table S5). Strikingly, this opposite allelic direction
was also observed when comparing liver with SAT, VAT and
muscle, tissues that were all obtained from exactly the same set of
individuals (Figure S11).
Another notable gene with an opposite allelic direction is
ORMDL3. Although its function remains unclear, genetic variants
near ORMDL3 are associated with various immune-related
diseases, including asthma, type 1 diabetes, Crohn’s diseases,
ulcerative colitis and primary biliary cirrhosis [25]–[29]. ORMDL3
had a genome-wide significant cis-eQTL in blood and its
association in SAT was showing near-genome-wide significance
(Figure S12). All disease-associated SNPs in this locus showed
association in cis with the expression level of ORMDL3 (Table S6),
including the functional variant rs12936231 that has been
implicated to play a causal role in chromatin remodeling [30].
The risk alleles for asthma and preventive alleles for other
autoimmune diseases showed consistent up-regulation in blood
(and were also reported in LCLs) [25], [30]. However, to our
surprise, the effect in SAT was completely reversed, leading to
down-regulation.
Although we have only provided a few examples here, these
observations indicate that conclusions drawn about mechanistic
up- or down-regulation from a single tissue cannot necessarily be
translated to other tissues, as they may sometimes lead to
completely different conclusions depending on the tissues studied.
In the supplementary material (Tables S7, S8, S9, S10 and Figures
S13, S14, S15, S16), we have summarized the observed tissue-
dependent regulation for 156 genes that have been reported to be
associated with complex traits at P=5610
28 (based on the genes,
mentioned in the Catalog of Published Genome-wide Association
Studies, as of 16/09/2011). Some of these plots also show that the
genetic regulation of gene expression is sometimes even more
complicated than what we have described here: some genes can
have multiple cis-eQTL that were either shared or specific to the
tissues, e.g, the association of MTMR3 gene that was associated
with lung cancer [31], Nephrophaty [32], and inflammatory bowel
disease [33], [34] (Figure S17).
The four categories of tissue-dependent cis-regulation we have
observed can be explained by two molecular models: 1) the tissue-
dependent use of the same causal variant, i.e., the same eSNPs tag
the same causal variant that is activated differentially by tissue-
dependent factors; 2) the tissue-dependent causal variants, i.e., the
same or different eSNPs tag different causal variants upon the
tissues under study. The extent of the linkage disequilibrium (LD)
between the causal variants and tag eSNPs, and the direction of
effect of the regulatory factors (e.g., stimulating or suppressing the
expression) and the size of their effects could lead to the
observations of different categories (Figure 4).
Discussion
Gene expression levels are partly determined by genetic
variation, and eQTL mapping in different cell types and tissues
has identified many cis-eQTL. However, the effect of cis-eQTL is
strongly dependent upon the studied tissue. In this study, we
compared the genetic architecture of gene expression regulation in
blood and four non-blood primary tissues. We detected that the
majority (71.3%) of the detected probes under genetic control
(eProbes) show a concordant association across tissues. However, the
remaining 28.7% of the eProbes show discordant, tissue-dependent
regulation. Strikingly, many of those discordantly associated eProbes
are affected by multiple, independent eSNPs. We followed up the
genes under tissue-dependent regulation and identified four
different mechanisms: specific regulation, alternative regulation,
different effect size, and opposite allelic direction. We are the first
to provide a comprehensive landscape of the different mechanisms
of tissue-dependent cis-regulation. Of the four mechanisms
identified, the opposite allelic direction mechanism, where alleles
can have opposing effects on gene expression between tissues is of
particular interest: Although this mechanism is less common than
the other three, it has important implications for inferring the
transcriptional effects of alleles from other tissue data, especially on
the susceptibility risk alleles for complex diseases. The use of
different tissues could result in completely the opposite conclusion!
This finding highlights the great importance of investigating
disease-relevant tissues in order to correctly characterize the
functional effects of disease-associated variants.
We observed that SNPs at various transcriptional regulatory
regions more often than expected exert tissue-dependent regula-
tion, although most of the eSNPs were located at intergenic and
gene intronic regions where functions remain undefined. Howev-
er, we must emphasize that the causal variants remained
undefined. Furthermore, because of the LD structure, although
the same eSNPs can be associated with the expression of the same
gene in different tissues, this does not necessarily mean that the
same regulatory variants act in the different tissues. We have
proposed two molecular models and suggested that tissue-
dependent cis-regulations can be explained by the tissue-depen-
dent use of the same causal variants or by the use of different
tissue-dependent causal variants. Further fine-mapping and
functional analyses are needed to identify the causal variants and
to understand how they are used in different tissues due to the
limited resolution of cis-eQTL mapping: It is known that the size of
regulatory cis-elements generally is only a few base pairs (i.e., the
binding sites of transcription factors or microRNAs), whereas the
size of linkage disequilibrium blocks is generally in a range of 10–
100 kb [35]. Furthermore, as the molecular models that we have
proposed are quite simple, we cannot exclude other molecular
mechanisms acting in these processes, e.g., the competition of
different regulatory factors and binding sites in different tissues, or
the role of tissue-specific methylation [36], [37] and chromatin
remodeling [38], etc.
It is well known that trait-associated SNPs are more likely to
have effects on gene expression but, to our surprise, we found that
they are also more likely to exert tissue-dependent effects. This
observation adds an extra layer of complexity to complex traits.
We acknowledge that our study has some limitations: We
compared cis-regulation between peripheral blood and four rather
small non-blood tissues. We lacked statistical power to compare
Mechanisms Underlying Tissue-Dependent cis-eQTL
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the identified discordant eQTLs are determined by the limited
tissues that we studied Thirdly, although we corrected for
substantial expression differences across samples by employing
principal component analysis, it is still possible that some of the
observed tissue-dependent cis-regulation can be due to the tissue
heterogeneity (i.e. different proportions of cell types per tissue).
Likewise it is also possible that some of the identified discordant cis-
eQTL could be due to differences in the base-line expression
between tissues. However, we observed this to be the case for both
concordant and discordant cis-eQTL when investigating the
original (non-PCA corrected) expression data (see Table S11).
Nevertheless our results indicate that natural genetic varation
can affect gene expression levels in complex ways. Further analyses
using different tissues and specific cell types and using larger
sample sizes are required to gain a deeper understanding of the
genetic variation of gene expression and to gain better insight into
the full complexity of disease.
Figure 4. Molecular models of tissue-dependent cis-regulation. The observed tissue-dependent cis-regulations can be explained by two
molecular models: (A) the tissue-dependent use of the same causal variants, or (B) the use of tissue-dependent causal variants. The ovals indicate the
two regulatory factors (e.g., transcription factors) that play regulatory roles in different tissues (brown in tissue 1 and purple in tissue 2). These factors
can recognize the same or different cis-elements (the yellow region). The genetic variants are shown as SNPs with A/G alleles. The SNPs in red are
causal variants and the SNPs in blue are tag SNPs. The red line between them indicates the linkage disequilibrium. The arrows indicate the effect of
regulatory factors, here the up arrows represent expression stimulators and the down arrows expression suppressors. The size of the arrows indicates
the size of the differences between the expression of A and G alleles, i.e., the cis-eQTL effect size.
doi:10.1371/journal.pgen.1002431.g004
Mechanisms Underlying Tissue-Dependent cis-eQTL
PLoS Genetics | www.plosgenetics.org 8 January 2012 | Volume 8 | Issue 1 | e1002431Materials and Methods
Genotyping and Expression Profiling on Liver, Muscle,
and Adipose Fat Tissues from the Same Population
Subjects. From April 2006 to January 2009, 85 morbidly
obese Dutch subjects (23 male and 62 female subjects) with a body
mass index (BMI) between 35 and 70 were included in the study.
They all underwent elective bariatric surgery at the Department of
General Surgery, Maastricht University Medical Centre. Patients
with acute or chronic inflammatory diseases (e.g., autoimmune
diseases), degenerative diseases, reported alcohol consumption
(.10 g/day), and/or using anti-inflammatory drugs were
excluded. The average age of the subjects was 43.9 with a range
of 17 and 67 years. This study was approved by the Medical
Ethical Board of Maastricht University Medical Centre, in line
with the guidelines of the 1975 Declaration of Helsinki. Informed
consent in writing was obtained from each subject personally. The
subject information was provided in Table S1.
Genotyping. Venous blood samples were obtained after
8 hours fasting on the morning of surgery. DNA was extracted
from this blood using the Chemagic Magnetic Separation Module
1 (Chemagen) integrated with a Multiprobe II Pipeting robot
(PerkinElmer). All samples were genotyped using Illumina
HumanOmni1-Quad BeadChips that contain 1,140,419 SNPs.
Genotyping was performed according to standard protocols from
Illumina.
RNA profiling in four tissues. Wedge biopsies of liver,
visceral adipose tissue (VAT, omentum majus), subcutaneous adipose
tissue (SAT, abdominal), and muscle (musculus rectus abdominis) were
taken during surgery. RNA was isolated using the Qiagen Lipid
Tissue Mini Kit (Qiagen, Crawley, West Sussex, UK, 74804).
Assessment of RNA quality and concentration was done with an
Agilent Bioanalyzer (Agilent Technologies, Santa Clara, USA).
Starting with 200 ng of RNA, the Ambion Illumina TotalPrep
Amplification Kit was used for anti-sense RNA synthesis,
amplification, and purification according to the protocol
provided by the manufacturer (Ambion, Austin, USA). 750 ng of
complementary RNA was hybridized to Illumina HumanHT12
BeadChips and scanned on the Illumina BeadArray Reader. Raw
probe intensity data for these samples was extracted using
Illumina’s BeadStudio Gene expression module v3.2 (No
background correction was applied, nor did we remove probes
with low expression).
Genotyping and Expression Profiling on Blood
Subjects. The genetical genomics samples for blood were
collected from unrelated Dutch individuals in four studies: 324
healthy individuals were collected in the University Medical
Centre Utrecht, 414 amyotrophic lateral sclerosis (ALS) patients
were collected in the University Medical Centre Utrecht, 49
ulcerative colitis (UC) patients from a part of the inflammatory
bowel disease (IBD) cohort of the University Medical Centre
Groningen, and 453 patients with chronic obstructive pulmonary
disease (COPD) were collected with the NELSON study. All
samples were collected after informed consent and approved by
local ethical review boards. Individual sample information is
provided in Table S1.
Genotyping and imputation. DNA from all samples was
hybridized to oligonucleotide arrays from Illumina. 324 healthy
individuals and 414 ALS patients were genotyped using the
Hap370 platform. The 453 COPD patients and 49 UC patients
were genotyped on the 610-Quad platform. Because the subjects
with liver, muscle, adipose fat tissues were genotyped using more
intensive genotyping platform Illumina HumanOmni1-Quad
BeadChips, we further used program IMPUTE v2 to impute the
genotypes of SNPs that presented in Omni1-Quad chips but not
directly genotyped on Hap370 and 610-Quad platform [39]. The
reference panel for imputation was the CEU population from
HapMap release 22. The directly genotyped SNPs were coded as
0, 1 or 2, while the imputed SNP dosage values were called at a
0.95 confidence level, ranging between 0 and 2. In this way, we
obtained the genotype of the same set of 1,140,419 SNPs for all
five tissues under study.
RNA profiling. Anti-sense RNA was synthesized, amplified
and purified using the Ambion Illumina TotalPrep Amplification
Kit (Ambion, USA) following the manufacturers’ protocol.
Complementary RNA was hybridized to Illumina HumanHT-12
arrays and scanned on the Illumina BeadArray Reader. Raw
probe intensity data for these samples was extracted using
Illumina’s BeadStudio Gene expression module v3.2 (No
background correction was applied, nor did we remove proves
with low expression).
Genotyping and Expression Profiling in an Independent
Blood Dataset of 229 Samples
Subjects. To ascertain whether our method for identifying
tissue-dependent cis-eQTL was robust, we compared the large
peripheral blood with an independent blood eQTL dataset that
comprised 229 samples. We have described this cohort in previous
studies [9], [18]. In brief, this study comprised 111 English celiac
disease patients, 59 Dutch amyotrophic lateral sclerosis patients
and 59 Dutch health controls. The peripheral blood (2.5 ml) was
collected with the PAXgene system (PreAnalytix GmbH, UK).
Genotyping and imputation. The samples were genotyped
using the Illumina (Illumina, San Diega, USA) HumanHap300
platform. We further used IMPUTE v2 to impute the genotypes of
all HapMap II SNPs. The reference panel for imputation was the
CEU population from HapMap release 22. The directly
genotyped SNPs were coded as 0, 1 or 2, while the imputed
SNP dosage values were called at a 0.95 confidence level, ranging
between 0 and 2.
RNA profiling. Anti-sense RNA was synthesized amplified
and purified using the Ambion Illumina TltalPrep Amplification
Kit (Ambion, USA) following the manufacturers’ protocol.
Complementary RNA was hybridized to Illumina HumanRef-8
v2 arrays (further referred to as H8v2) and scanned on the
Illumina BeadArray Reader.
Normalization and PCA Correction
The raw expression intensities from five tissues were jointly
quantile normalized and log2 transformed. We further applied a
principal component analysis (PCA) on expression correlation
matrix and observed that genes are differentially expressed among
different tissue types (Figure S1). We argue that the dominant
principal components (PCs) will primarily capture sample
differences in expression that reflect physiological or environmen-
tal variation (e.g., tissue type and phenotype difference) as well as
systematic experimental variation (e.g. batch and technical effect).
In order to target the difference in the genetic variation of
expression among tissues, we removed the global variation in
expression among tissues by using the residual expression for each
probe in each tissue after removing 50 PCs (identical to what we
have described before [18]). Our previous analysis on the same
dataset showed that the number of significantly detected cis-eQTL
probes increased two-fold when 50 PCs were removed from the
expression data (see Figure S7 in ref [18]). For the independent
blood dataset with 229 subjects, we followed the same quantile
normalized and PCA correction.
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We tested population stratification between the two cohorts
using the program PLINK (http://pngu.mgh.harvard.edu/,
purcell/plink/strat.shtml). This program uses complete linkage
agglomerative clustering, based on pair-wise identity-by-state (IBS)
distances. The fact that all the individuals from both cohorts were
clustered together indicates there was no population stratification.
We also checked the allelic frequencies between the two cohorts by
treating the 85 individuals with four tissue samples as cases and the
1,240 individuals for blood samples as controls. For the imputed
SNPs, we used the genotype with highest probability as the
discrete genotype for QC purposes. We removed SNPs that
showed significant differences in allele frequency at P,0.01. Then
the SNPs were quality controlled for minor allelic frequency .5%,
a call rate .95% and an exact Hardy-Weinberg (HWE) P
value.0.001. To make certain on the directions of the allelic effect
on gene expression (up-regulating or down-regulating), we further
removed SNPs with two types of transversion alleles (A/T and G/
C) and confined our analysis to SNPs with transition alleles (A/G
or C/T) and other types of transversion alleles (A/C or G/T). This
quality control resulted in 710,035 SNPs for further analysis.
eQTL Discovery
In order to detect cis-eQTLs, analysis was confined to those
probe-SNP combinations for which the distance from the probe
transcript midpoint to SNP genomic location was #1 Mb. For
each probe-SNP pair, we used Spearman correlation to detect
association between SNPs and the variations of the gene
expression in liver, SAT, VAT, muscle and blood, respectively.
We calculated the Spearman correlation coefficient and corre-
sponding P values and subsequently transformed this into a Z-
score. To maximize the power of eQTL discovery in non-blood
tissues, we further performed meta-analysis for four non-blood
tissues that combines the association signals across the four non-
blood tissues under study. An overall, joint P value was calculated
using a weighted (square root of the dataset sample number) Z-
method. Please see the ref [40] for a comprehensive overview of
this method.
To correct for multiple testing, we controlled the false-discovery
rate (FDR) at 0.05: the distribution of observed p-values was used
to calculate the FDR, by comparison with the distribution
obtained from permuting expression phenotypes relative to
genotypes 100 times. At FDR=0.05 level, the significance P
value threshold was 1.37610
25 for significantly associated probe-
SNP pairs in liver, 2.07610
25 for significant association in SAT,
1.54610
25 for significant association in VAT, 5.64610
26 for
significant association in muscle, 4.8610
24 for significant
association in blood and 1.10610
24 for significant association in
the meta-analysis of four non-blood tissues. For these significant
probe-SNP pairs, we termed the corresponding SNP, probe and
genes as expression SNP (eSNP), regulated probe (eProbe) and
regulated genes (eGenes), respectively.
Conditional Regression Analysis to Detect Independent
eSNPs
Due to the linkage disequilibrium among the tested SNPs, we
usually found numerous eSNPs for each eProbe. In order to detect
independent eSNPs, we performed conditional regression analysis
for the eProbes per tissue type. For each eProbe, we first regressed out
the main effect of the top eSNP. We then subjected the residuals to
eQTL mapping to detect potential secondary, independent eSNPs.
We again controlled the false discovery at 0.05 by running 100, as
described before in the method section ‘‘eQTL discovery’’. If
secondary eSNPs were present, we repeated the entire procedure
to detect tertiary eSNPs by regressing out both the primary and
secondary effect (using appropriate multivariate regression anal-
ysis). This procedure was repeated until no significant associations
were detected any more.
Sampling Approach to Identify Tissue-Dependent eQTL
Comparing blood and non-blood tissues. For each of the
200,629 probe-SNP pairs that was significantly associated at FDR
0.05 level, we further assessed whether the detected Z-scores
differed per tissue. We used the Z-scores in blood as a reference
because the blood samples were independent from other tissue
samples and the sample size was much larger. To correct for the
sample size difference, we, out of the 1,240 blood samples,
randomly selected without replacement the same number of
samples for the comparison with liver (N=74), SAT (N=83),
VAT (N=77) and muscle (N=62). For a certain probe-SNP pair,
we re-calculated the association Z-score in blood for the selected
sample size. The sampling procedure was repeated 100 times. We
subsequently fitted a generalized extreme value distribution
(GEVD) for the Z-scores of 1006 sampling procedures in blood.
GEVD is a flexible model with three parameters: location (c), scale
(b) and shape (a). GEVD can resemble different distributions with
different settings of parameters. For example, when a=0, it
resembles the Gumbel types of distributions (Type I); when a.0, it
resembles the Frechet types of distributions (Type II); when a,0, it
resembles the Weibull types of distributions (Type III). Therefore,
fitting the GEVD can permit us to estimate realistic distribution of
the Z-scores of this certain probe-SNP pair in blood (Figure S3). We
then assessed the deviation of the Z-score of the same probe-SNP
pair inthe otherfour tissues from theestimatedGEVD inblood and
computed P value for the difference of Z-scores between tissues. We
did this analysis in R (version 2.10.1) using the package evd:
Functions for extreme value distributions (version 2.2–4). This
analysis was done for each of the 200,629 probe-SNP pairs and
between blood and each of four non-blood tissues. Considering the
possible dependence of the eQTL effect among tissues, the
significance was controlled at the conserved Bonferroni-corrected
0.05, corresponding to a P value of 6.23610
28 (0.05/200,629
probe-SNP pairs/4 tissue comparisons). The probe-SNP pairs with
a P#6.23610
28 were called‘‘discordant associations’’,whileprobe-
SNP pairs with P.6.23610
28 were called ‘‘concordant
associations’’. The expression profiling in all five tissues used the
same platform. Therefore, the discordant association cannot be
explained by the hybridization efficiency. Because all of the tested
SNPs weredirectly genotyped in non-blood tissues but most of them
wereimputedin blood,we further checked whether the discordance
was caused by the imputation. We did not observe that imputation
accuracy might confound our results: 69.3% of the discordant
eSNPs were imputed in blood whereas 68.0% of the concordant
eSNPs were imputed in blood (Fisher’s exact test P value=0.60).
We also assessed whether there was heterogeneity in effect present
when comparing the different subgroups of phenotypes. We did not
find evidence this to be the case (see Table S6 in ref [18]).
Comparing two independent blood datasets. To further
validate the tissue-dependent effect we had detected, we compared
the cis-eQTL effects between the blood dataset HT12 and H8v2,
using the same sampling procedure as described above. Because of
the difference of expression platform, we could only make
comparisons for those probes that were present in both datasets.
We only investigated SNPs that showed similar allele frequencies
between the two blood datasets (SNPs with allele frequency
P,0.01 were excluded from analysis and as the H8v2 dataset
contained 111 celiac disease patients that were nearly all HLA-
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this analysis). After filtering we could compare 93,656 probe-SNP
pairs.
Enrichment for SNP Properties
The minor allele frequency (MAF) and function properties of
eSNPs were annotated by the web-based tool SNP Annotation and
Proxy Search (SNAP) (www.broadinstitute.rog/mpg/snap) [41],
using the CEU population panel from HapMap release 22. We
performed Fisher’s exact test to compare the enrichment between
eSNPs with a tissue-dependent effect on expression across tissues
and eSNPs with a static effect.
Cis-eQTL Analysis of Trait-Associated SNPs
To directly assess the effect of trait-associated SNPs on gene
expression, we confined our cis-eQTL analysis to 1,954 SNPs (with
alleles A/G) that were associated with complex traits at
P,5.0610
28 in the ‘Catalog of Published Genome-wide Associ-
ated Studies’ (per 16 September 2011) [20] and assessed the tissue-
dependency of eQTL effect across the tissues, following the same
analysis and permutation procedures. The cis-eQTL significance
threshold P values were set at P=4.6610
23 in blood, 2.6610
24 in
liver, 2.5610
24 in muscle, 1.8610
24 in VAT and 3.2610
25 in
SAT, and 1.1610
23 for the meta-analysis of four non-blood tissue.
At these levels, a total of 2,990 probe-SNP pairs were significant in
at least one eQTL analysis.
Characterizing the Tissue-Dependent Mechanisms of Cis-
Regulation
To characterize the tissue-dependent mechanisms of cis-
regulation, we reasoned that comparing the association at a single
probe-SNP level cannot provide a complete picture of the tissue-
dependent genetic determinants of gene expression. To gain
further insight into the tissue-dependent cis-regulation, we
extended analysis for the eProbes with discordant cis-eQTL that
were determined by single probe-SNP comparison and compared
their whole association profiles across tissues. The association
profile refers to the set of the absolute Z-scores of all N number of
the tested SNPs within 1 Mb distance from the middle point of
probe under study: i.e., {|Z1|, |Z2|,| Z3|, … |Zn|}. Such a
profile can represent the combined association signals of the
multiple independent eSNPs and their linkage disequilibrium.
Most of the eProbes only showed significant association in blood
and were not significantly associated in the smaller non-blood
tissues. For those eProbes, we had limited statistical power to
determine whether the association in non-blood tissues is truly
absent or is not detected due to power issues. Therefore, we
confined our comparison of association profiles to the eProbes that
were significantly associated in non-blood tissues and compared
them to those in blood. To assess the similarity of association
profiles across tissues, we computed Pearson correlations coeffi-
cient (r) of the association profiles between two tissues. Because the
SNPs were likely in strong linkage equilibrium, there is strong
dependency among the Z-scores within the association profile. To
determine the empirical threshold for the significance of the
correlation between the association profiles and considering the
dependency of the SNPs, we performed permutation analysis by
randomly assigning genomes to the individuals per tissue type. We
thus obtained the association profiles per probe per tissue for the
permuted genotypes. These permuted association profiles retained
the same correlation structure among SNPs and the Pearson
correlation coefficient between the permuted association profiles
(r0) would mainly explain the correlation among SNPs. We
repeated this permutation 100 times and determined the empirical
threshold rthres=0.21 at FDR 0.05 level using the model
(FDR=n0{r0$rthres}/n1{r$rthres), where r and r0 refer to the
Pearson correlation coefficient of real data and permuted data,
respectively; n refers to the number of probes where r$rthres and n0
refers to the average number of probes where r0$rthres from 1006
permutations.
Based on the correlation of association profiles between tissues,
we identified four different categories of tissue-dependent genetic
regulation of gene expression. If the association profiles for one
single probe did not correlate at all between two tissues (r,0.21),
we further checked whether the eProbe was significant in both
tissues: if the probe had a significant association in one tissue but
not in the other, we deemed this ‘‘specific cis-regulation’’; if instead
the eProbe was significant in both tissues, but was associated to
different (unlinked) eSNPs in the different tissues, we deemed it
‘‘alternative cis-regulation’’. For those association profiles where
two tissues showed a correlation (r$0.21), we checked the
direction and the effect size of allelic effect on gene expression:
if the allelic direction was the same and the effect size was
different, we concluded the eProbe belonged to the category
‘‘different effect size’’; if the allelic direction was instead opposite,
the probes had tissue-dependent regulation with an ‘‘opposite
allelic direction’’.
Differential Expression
For the probes with tissue-dependent cis-regulation, we assessed
whether they were also differential expressed between the tissues
where they showed different cis-regulation. To do so, we relied
upon the quantile-normalized expression intensity before any
removal of the first 50 principal components. For each discordant
eProbe, we used a Wilcoxon Mann-Whitney U test to assess the
differential expression between the tissues. We performed the
same analysis for a random set of concordant eProbes, equal in size
to the set of discordant eProbes. The significance of differential
expression was controlled at a Bonferroni-corrected P value 0.05
level.
Accession Numbers
Expression data for both blood tissue and four non-blood
dataset have been deposited in GEO with accession numbers
GSE20142 (1,240 peripheral blood samples, hybridized to HT12
arrays) and GSE22070 (subcutaneous adipose, visceral adipose,
muscle and liver samples). The expression data of the validation
blood eQTL dataset (229 samples) has been deposited in GEO
with accession number GSE203332.
Supporting Information
Figure S1 The effect of removing principal components from
expression data.
(PDF)
Figure S2 Flowchart for the analysis of the tissue-dependent cis-
eQTL across the five human tissues.
(PDF)
Figure S3 Overlap of the associated probe-SNP pairs across the
tissues.
(PDF)
Figure S4 Overlap of the associated probe-SNP pairs across the
single-tissue analysis and meta-analysis.
(PDF)
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association strength between blood and four other tissues (liver,
SAT, VAT and muscle). As an example, for liver, we randomly
sampled 74 subjects out of the 1,240 blood subjects (making the
same sample size as for the liver tissue dataset) and re-measured
the association strength for each significantly associated probe-
SNP pair, in terms of Z-scores. This sampling procedure was
repeated 100 times. The histogram showed the Z-scores distribution
of a certain cis-eQTL in 74 blood subjects. We then assessed the
deviation of the Z-scores detected in liver (the red arrow) from the
distribution of Z-scoress in blood, by fitting the extreme value
distribution (EVD) (the red line). The same analysis was performed
for comparing blood with SAT, VAT and muscle, by randomly
sampling N number of blood subjects (N=83 for the SAT sample
size; 77 for the VAT sample size, and 62 for the muscle sample
size, respectively).
(PDF)
Figure S6 The overlap of discordantly associated probe-SNP
pairs.
(PDF)
Figure S7 The comparison of Z-scores between two indepen-
dent blood datasets. The comparison of cis-eQTL effect was
confined to the set of 93,656 probe-SNP pairs that have been
tested in two independent blood datasets, e.g., a discovery set of
1,240 subjects profiled on the Illumina HT12 expression platform
(HT12) and a validation set of 229 subjects profiled on the
Illumina H8v2 expression platform (H8v2). The Z-scores of cis-
eQTL in the discovery set were the mean of Z-scores from 1006
taking a sample of 229 out of the 1,240 blood subjects. The gray
dots indicate the concordantly associated probe-SNP pairs
between the two blood samples. The red dots indicate the
discordantly associated probe-SNP pairs (the false-positive tissue-
dependent association). The black line is the diagonal line.
(PDF)
Figure S8 The probes-SNP distance for associated probe-SNP
pairs. The distance was calculated by the base pair position (bp) of
SNPs minus the bp position of the middle point of the probes.
(PNG)
Figure S9 Probe-SNP distance for 2,794 eProbes in blood with
multiple independent eSNPs.
(PDF)
Figure S10 The discordant probe-SNP pairs vs. the probe-SNP
distance. The histogram shows the number the probe-SNP pairs
with different distance. The numbers on each bar show the total
number of probe-SNP pairs and the percentage of pairs with
discordant association. The 262 table for Fisher’s exact test is
shown.
(PDF)
Figure S11 The direction of allelic effect of rs5751777 on DDT
expression. The correlation between the genotype of rs5751777
and the expression intensity of DDT gene (residual variance after
50 PCs removed) in five tissues. Each dot represents one subject,
red for females and blue for males. The X-axis represents the
genotypes and the Y-axis represents the expression rank of the
probes.
(PDF)
Figure S12 The opposite association of ORMDL3 gene between
blood and SAT. The x-axis is the genome position based on
genome build 36.3 (in Mb). The y-axis at the left is the association
profiles in terms of Z-scores. The Z-scores in blood, represented as
the red dots, has been weighted by the square root of the sample
size, corresponding to the compared tissue. The blue dots
represent the Z-scores in SAT. The dashed green line indicates
the significance level at FDR 0.05. For a better illustration of allelic
direction, we assigned the association Z-scores in blood a positive
value. If the allelic direction in SAT is the same as that in blood,
the Z-scores in SAT are positive too; otherwise, the Z-scores in SAT
are negative.
(PDF)
Figure S13 The association profiles of the selected trait-
associated genes that show discordant association between blood
and liver. The x-axis is the genome position based on genome
build 36.3. The y-axis at the left is the association profiles in terms
of the Z-score. The Z-score in blood, represented as the red dots or
orange dots. The red dots refer to the Z-scores that have been
weighted by the square root of the sample sizes, corresponding to
the compared tissue. For the clarity of subtle effect in blood, the
weak association in blood was shown as orange dots if the Z-scores
have not been weighted by the sample size, i.e., the Z-scores
reported in 1,240 subjects. The blue dots represent the Z-scores in
liver. The dashed green line indicates the Z-score 3.49,
representing the significance level in blood at FDR 0.05. The
right panel shows the correlation of the absolute association Z-
scores between two tissues. The rho-value indicates the correlation
coefficient of the Pearson correlation.
(PDF)
Figure S14 The association profiles of the selected trait-
associated genes that show discordant association between blood
and SAT. The x-axis is the genome position based on genome
build 36.3. The y-axis at the left is the association profiles in terms
of the Z-score. The Z-score in blood, represented as the red dots or
orange dots. The red dots refer to the Z-scores that have been
weighted by the square root of the sample sizes, corresponding to
the compared tissue. For the clarity of subtle effect in blood, the
weak association in blood was shown as orange dots if the Z-scores
have not been weighted by the sample size, i.e., the Z-scores
reported in 1,240 subjects. The blue dots represent the Z-scores in
SAT. The dashed green line indicates the Z-score 3.49,
representing the significance level in blood at FDR 0.05. The
right panel shows the correlation of the absolute association Z-
scores between two tissues. The rho-value indicates the correlation
coefficient of the Pearson correlation.
(PDF)
Figure S15 The association profiles of the selected trait-
associated genes that show discordant association between blood
and VAT. The x-axis is the genome position based on genome
build 36.3. The y-axis at the left is the association profiles in terms
of the Z-score. The Z-score in blood, represented as the red dots or
orange dots. The red dots refer to the Z-scores that have been
weighted by the square root of the sample sizes, corresponding to
the compared tissue. For the clarity of subtle effect in blood, the
weak association in blood was shown as orange dots if the Z-scores
have not been weighted by the sample size, i.e., the Z-scores
reported in 1,240 subjects. The blue dots represent the Z-scores in
VAT. The dashed green line indicates the Z-score 3.49,
representing the significance level in blood at FDR 0.05. The
right panel shows the correlation of the absolute association Z-
scores between two tissues. The rho-value indicates the correlation
coefficient of the Pearson correlation.
(PDF)
Figure S16 The association profiles of the selected trait-
associated genes that show discordant association between blood
and muscle. The x-axis is the genome position based on genome
Mechanisms Underlying Tissue-Dependent cis-eQTL
PLoS Genetics | www.plosgenetics.org 12 January 2012 | Volume 8 | Issue 1 | e1002431build 36.3. The y-axis at the left is the association profiles in terms
of the Z-score. The Z-score in blood, represented as the red dots or
orange dots. The red dots refer to the Z-scores that have been
weighted by the square root of the sample sizes, corresponding to
the compared tissue. For the clarity of subtle effect in blood, the
weak association in blood was shown as orange dots if the Z-scores
have not been weighted by the sample size, i.e., the Z-scores
reported in 1,240 subjects. The blue dots represent the Z-scores in
muscle. The dashed green line indicates the Z-score 3.49,
representing the significance level in blood at FDR 0.05. The
right panel shows the correlation of the absolute association Z-
scores between two tissues. The rho-value indicates the correlation
coefficient of the Pearson correlation.
(PDF)
Figure S17 Association profiles of MTMR3 in blood and liver.
The x-axis is the genome position based on genome build 36.3 (in
Mb). The y-axis at the left indicates the association Z-score. The Z-
scores in blood, represented as the red dots, have been weighted by
the square root of the sample size, corresponding to the compared
tissue. The blue dots represent the Z-scores in SAT. The dashed
green line indicates the Z-scores 3.49, representing the significance
level in blood at FDR 0.05. The right panel shows the correlation
of the absolute association Z-scores between two tissues. The r-value
indicates the correlation coefficient of the Pearson correlation.
(PDF)
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